| Marjorie Nicole Harvill-brooks, DO | |
|
940 Royal Ave, Suite 350, Medford, OR 97504-6193 | |
| (541) 732-7460 | |
| (541) 732-7461 |
| Full Name | Marjorie Nicole Harvill-brooks |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 27 Years |
| Location | 940 Royal Ave, Medford, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831148196 | NPI | - | NPPES |
| 500634857 | Other | OR | MEDICAID |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Medford Medical Center | Medford, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 5294623245 | 159 |
News Archive
By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin.
What was hoped to be a promising new drug to protect the kidneys has failed to benefit diabetes patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
By cloaking nanoparticles in the membranes of white blood cells, scientists at The Methodist Hospital Research Institute may have found a way to prevent the body from recognizing and destroying them before they deliver their drug payloads. The group describes its "LeukoLike Vectors", or LLVs, in the January issue of Nature Nanotechnology.
Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry.
Alan H. Lockwood, MD, professor of neurology and nuclear medicine in the University at Buffalo's School of Medicine and Biomedical Sciences calls the Japanese Health Ministry's advice not to give tap water to infants "prudent."
› Verified 4 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093976243 PECOS PAC ID: 3476450560 Enrollment ID: O20031217000186 |
News Archive
By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin.
What was hoped to be a promising new drug to protect the kidneys has failed to benefit diabetes patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
By cloaking nanoparticles in the membranes of white blood cells, scientists at The Methodist Hospital Research Institute may have found a way to prevent the body from recognizing and destroying them before they deliver their drug payloads. The group describes its "LeukoLike Vectors", or LLVs, in the January issue of Nature Nanotechnology.
Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry.
Alan H. Lockwood, MD, professor of neurology and nuclear medicine in the University at Buffalo's School of Medicine and Biomedical Sciences calls the Japanese Health Ministry's advice not to give tap water to infants "prudent."
› Verified 4 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568547503 PECOS PAC ID: 5294623245 Enrollment ID: O20040310000315 |
News Archive
By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin.
What was hoped to be a promising new drug to protect the kidneys has failed to benefit diabetes patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
By cloaking nanoparticles in the membranes of white blood cells, scientists at The Methodist Hospital Research Institute may have found a way to prevent the body from recognizing and destroying them before they deliver their drug payloads. The group describes its "LeukoLike Vectors", or LLVs, in the January issue of Nature Nanotechnology.
Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry.
Alan H. Lockwood, MD, professor of neurology and nuclear medicine in the University at Buffalo's School of Medicine and Biomedical Sciences calls the Japanese Health Ministry's advice not to give tap water to infants "prudent."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marjorie Nicole Harvill-brooks, DO Po Box 3158, Portland, OR 97208-3158 Ph: (541) 732-7460 | Marjorie Nicole Harvill-brooks, DO 940 Royal Ave, Suite 350, Medford, OR 97504-6193 Ph: (541) 732-7460 |
News Archive
By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin.
What was hoped to be a promising new drug to protect the kidneys has failed to benefit diabetes patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
By cloaking nanoparticles in the membranes of white blood cells, scientists at The Methodist Hospital Research Institute may have found a way to prevent the body from recognizing and destroying them before they deliver their drug payloads. The group describes its "LeukoLike Vectors", or LLVs, in the January issue of Nature Nanotechnology.
Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry.
Alan H. Lockwood, MD, professor of neurology and nuclear medicine in the University at Buffalo's School of Medicine and Biomedical Sciences calls the Japanese Health Ministry's advice not to give tap water to infants "prudent."
› Verified 4 days ago
Anthony Eugene Ramsey, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 691 Murphy Road, Suite #202, Medford, OR 97504 Phone: 541-734-7733 Fax: 541-734-7744 | |
Dr. Daniel Alan Tomlinson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3170 State St, Medford, OR 97504 Phone: 541-864-8900 Fax: 541-245-3315 | |
Ms. Carissa Marie Ross, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3170 State St, Medford, OR 97504 Phone: 541-864-8900 Fax: 541-245-3315 | |
Daniel Albert Kahn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2911 Siskiyou Blvd, Medford, OR 97504 Phone: 541-789-5982 Fax: 541-789-5983 | |
Timothy B Hutchings, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 940 Royal Ave, Ste 350, Medford, OR 97504 Phone: 541-732-7460 Fax: 541-732-7461 | |
Lorie Jane Morgan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2859 State St, Suite 102, Medford, OR 97504 Phone: 541-282-6518 Fax: 541-282-6510 | |
Jennifer Veit Hall Jackson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 940 Royal Ave Unit 350, Medford, OR 97504 Phone: 541-732-7460 |